Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 665-672

  Furumoto, Katsuyoshi ^a   Arii, Shigeki ^a   Yamasaki, Seiji ^a   Mizumoto, Masaki ^a   Mori, Akira ^a   Inoue, Naoya ^a   Isobe, Naoki ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; FIBROBLAST; IMMUNE RESPONSE; KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; COLONIC NEOPLASMS; DENDRITIC CELLS; FIBROBLASTS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TRANSDUCTION, GENETIC;

EID: 0033855120     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<665::AID-IJC8>3.0.CO;2-F     Document Type: Article

References (46)

1. ALBERT, M.L., SAUTER, B. and BHARDWAJ, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature, 392, 86-89 (1998).
2. BARRATT-BOYES, S.M., WATKINS, S.C. and FINN, O.J., In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol., 158, 4543-4547 (1997).
3. BOTTOMLY, K., T cells and dendritic cells get intimate. Science, 283, 1124-1125 (1999).
4. BRAMSON, J.L., HITT, M., GAULDIE, J. and GRAHAM, F.L., Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther., 4, 1069-1076 (1997).
5. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F. and GATELY, M.K., Antitumor and anti-metastatic activity of interleukin 12 against murine tumors. J. exp. Med., 178, 1223-1230 (1993).
6. CHAN, S.H., KOBAYASHI, M., SANTOLI, D., PERUSSIA, B. and TRINCHIERI, G., Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol., 148, 92-98 (1992).
7. CHRIST, M., LUSKY, M., STOECKEL, F., DREYER, D., DIETERLE, A., MICHOU, A.I., PAVIRANI, A. and MEHTALI, M., Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol. Lett., 57, 19-25 (1997).
8. CROWLEY, M., INABA, K., WITMER-PACK, M. and STEINMAN, R.M., The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell. Immunol., 118, 108-125 (1989).
9. ENGELHARDT, J.F., LITZKY, L. and WILSON, J.M., Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther., 5, 1217-1229 (1994).
10. FALLARINO, F., UYTTENHOVE, C. BOON, T. and GAJEWSKI, T.F., Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12. Int. J. Cancer, 80, 324-333 (1999).
11. GABRILOVICH, D.L. CUNNINGHAM, H.T. and CARBONE, D.P., IL-12 and mutant p53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer. J. Immunother., 19, 414-418 (1997).
12. GAJEWSKI, T.F., PINNAS, M., WONG, T. and FITCH, F.W., Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol., 146, 1750-1758 (1991).
13. GATELY, M.K., WOLITZKY, A.G., QUNN, P.M. and CHIZZONITE, R., Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol., 143, 127-142 (1992).
14. HEUFLER, C., KOCH, F., STANZL, U., TOPAR, G., WYSOCKA, M., TRINCHIERI, G., ENK, A., STEINMAN, R.M., ROMANI, N., and SCHULER, G., Interleukin-12 is produced hy dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol., 26, 659-668 (1996).
15. HUNG, K., HAYASHI, R., LAFOND-WALKER, A., LOWENSTEIN, C., PARDOLL, D., and LEVITSKY, H., The central role of CD4(+) T cells in the antitumor immune response. J. exp. Med., 188, 2357-2368 (1998).
16. INABA, K., INABA, M., NAITO, M. and STEINMAN, R.M., Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J exp. Med., 178, 479-488 (1993).
17. INGULLI, E., MONDINO, A., KHORUTS, A. and JENKINS, M.K., In vivo detection of dendritic cell antigen presentarion to CD4(+) T cells. J. exp. Med., 185, 2133-2141 (1997).
18. KRONIN, V., WINKEL, K., SUSS, G., KELSO, A., HEATH, W., KIRBERG, J., VON BOEHMER, H., and SHORTMAN, K., A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157, 3819-3827 (1996).
19. LARSEN, C.P., RITCHIE, S.C., PEARSON, T.C., LINSLEY, P.S. and LOWRY, R.P., Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. exp. Med., 176, 1215-1220 (1992).
20. LEENEN, P.J., RADOSEVIC, K., VOERMAN, J.S., SALOMON, B., VAN ROOIJEN, N., KLATZMANN, D. and VAN EWIJK, W., Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J. Immunol., 160, 2166-2173 (1998).
21. LUTZ, M.B., KUKUTSCH, N., OGILVIE, A.L., ROSSNER, S., KOCH, F., ROMANI, N. and SCHULER, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. immunol. Methods, 223, 77-92 (1999).
22. MACATONIA, S.E., HOSKEN, N.A., LITTON, M., VIEIRA, P., HSIEH, C.S., CULPEPPER, J.A., WYSOCKA, M., TRINCHIERI, G., MURPHY, K.M. and O'GARRA, A., Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol., 154, 5071-5079 (1995).
23. - subclasses of dendritic cells direct the development of distinct helper cells in vivo. J. exp. Med., 189, 587-592 (1999).
24. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, ST., KAST, W.M., DELEO, A.B. and OTHERS, Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature (Med.), 1, 1297-1302 (1995).
25. NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J. and OTHERS, Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol., 153, 1697-1706 (1994).
26. NISHIOKA, Y., HIRANO, M., ROBBINS, P.D., LOTZE, M.T. and TAHARA, H., Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleu-kin 12. Cancer Res., 59, 4035-4041 (1999).
27. PORGADOR, A. and GILBOA, E., Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. exp. Med., 182, 255-260 (1995).
28. PULENDRAN, B., LINGAPPA, J., KENNEDY, M.K., SMITH, J., TEEPE, M., RUDENSKY, A., MALISZEWSKI, C.R. and MARASKOVSKY, E., Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-trealed mice. J. Immunol., 159, 2222-2231 (1997).
29. REEVES, M.E., ROYAL, R.E., LAM, J.S., ROSENBERG, S.A. and HWU, P., Retroviral transduction of human dendritic cells with a tumor associated antigen gene. Cancer Res., 56, 5672-5677 (1996).
30. RIBAS, A., BUTTERFIELD, L.H., MCBRIDE, W.H., JILANI, S.M., BUI, L.A., VOLLMER, C.M., LAU, R., DISSETTE, V.B., HU, B., CHEN, A.Y., GLASPY, J.A. and ECONOMOU, J.S., Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res., 57, 2865-2869 (1997).
31. RISSOAN, M.C., SOUMELIS, V., KADOWAKI, N., GROUARD, G., BRIERE, F., DE WAAL , MALEFYT, R. and LIU, Y.J., Reciprocal control of T helper cell and dendritic cell differentiation. Science, 283, 1183-1186 (1999).
32. RODOLFO, M., ZILOCCHI, C., MELANI, C., CAPPETTI, B., ARIOLI, I., PARMIANI, G. and COLOMBO, M.P., Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. J. Immunol. 157, 5536-5542 (1996).
33. SCHULER, G. and STEINMAN, R.M., Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. exp. Med., 186, 1183-1187 (1997).
34. SEDER, R.A., GAZZINELLI, R., SHER, A. and PAUL, W.E., Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. nat. Acad. Sci. Wash., 90, 10188-10192 (1993).
35. SPECHT, J.M., WANG, G., DO, M.T., LAM, J.S., ROYAL, R.E., REEVES, M.E., ROSENBERG, S.A. and HWU, P., Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. exp. Med., 186, 1213-1221 (1997).
36. SUSS, G. and SHORTMAN, K., A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. exp. Med., 183, 1789-1796 (1996).
37. SZABOLCS, P., MOORE, M.A. and YOUNG, J.W., Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J. Immunol., 154, 5851-5861 (1995).
38. TAHARA, H., ZEH, H.J., 3RD, STORKUS, W.J., PAPPO, I., WATKINS, S.C., GUBLER, U., WOLF, S.F., ROBBINS, P.D. and LOTZE, M.T., Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54, 182-189 (1994).
39. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH, H.J., 3RD, MCKINNEY, T.G., SCHREIBER, R.D., GUBLER, U., ROBBINS, P.D. and LOTZE, M.T., Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol., 154, 6466-6474 (1995).
40. TUTING, T., WILSON, C.C., MARTIN, D.M., KASAMON, Y.L., ROWLES, J., MA, D.I., SLINGLUFF, C.L., JR, WAGNER, S.N., VAN DER BRUGGEN, P., BAAR, J., LOTZE, M.T. and STORKUS, W.J., Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and INF-alpha. J. Immunol., 160, 1139-1147 (1998).
41. VOEST, E.E., KENYON, B.M., O'REILLY, M.S., TRUITT, G., D'AMATO, R.J. and FOLKMAN, J., Inhibition of angiogenesis in vivo by interleukin 12. J. nat. Cancer Inst., 87, 581-586 (1995).
42. VREMEC, D. and SHORTMAN, K., Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol., 159, 565-573 (1997).
43. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E. and WILSON, J.M., Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Sci. Acad. Sci. Wash., 91, 4407-4411 (1994).
44. YANG, Y., TRINCHIERI, G. and WILSON, J.M., Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature (Med.), 1, 890-893 (1995).
45. ZHONG, L., GRANELLI-PIPERNO, A., CHOI, Y. and STEINMAN, R.M., Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Europ. J. Immunol., 29, 964-972 (1999).
46. ZITVOGEL, L., TAHARA, H., ROBBINS, P.D., STORKUS, W.J., CLARKE, M.R., NALESNIK, M.A. and LOTZE, M.T., Cancer immunotherapy of established tumors wilh IL-12. Effective delivery by genetically engineered fibroblasts J. Immunol., 155, 1393-1403 (1995).